BDBM536440 (S)-5-(1-(2-((5-chloro- 2-(2-methyl-4-(oxetan-3- yl)piperazin-1-yl)pyridin- 4-yl)amino)-2-oxoethyl)- 4-oxo-4,6,7,8-tetrahydro- 1H-dipyrrolo[1,2-a:2',3'- d]pyrimidin-3-yl)-4- fluoro-2-hydroxy-3- methoxybenzamide::US11242351, Compound I-19

SMILES COc1c(O)c(cc(-c2cn(CC(=O)Nc3cc(ncc3Cl)N3CCN(C[C@@H]3C)C3COC3)c3nc4CCCn4c(=O)c23)c1F)C(N)=O

InChI Key InChIKey=ODEMQYGZWDFSNH-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 536440   

TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Human)
Ontario Institute For Cancer Research (Oicr)

US Patent
LigandPNGBDBM536440((S)-5-(1-(2-((5-chloro- 2-(2-methyl-4-(oxetan-3- y...)
Affinity DataKd:  26.6nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
In DepthDetails
US Patent